This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
ADDERALL 30 MG TABLET is a brand (anda) product labeled by Teva Pharmaceuticals USA Inc., priced at $12.2555 per EA under NDC 57844013001. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Feb 11, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
ADDERALL 30 MG TABLET
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
57844013001
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040422FDA Approved
2/11/2002
TE Code
AB
On Market Since
2/6/2014
Pharmacological Classes
Price Statistics
The NADAC for ADDERALL 30 MG TABLET has been published 649 times since Mar 19, 2014, and over the history we have for it it has risen 176.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.2555 per EA |
|---|---|
| All-time high | $12.2923 (Jul 15, 2026) |
| All-time low | $4.3830 (Sep 17, 2014) |
| 52-week high | $12.2923 |
| 52-week low | $11.1681 |
| Median price | $7.1525 |
| Average price | $7.5706 |
| Largest weekly change | +9.4% (Jan 9, 2019) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADDERALL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADDERALL 30 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $12.2555 per EA (NDC 57844013001), effective Aug 19, 2026.
How has the price of ADDERALL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADDERALL 30 MG TABLET has risen 176.5%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for ADDERALL 30 MG TABLET?
Since Mar 19, 2014, the NADAC for ADDERALL 30 MG TABLET has ranged from a low of $4.3830 (Sep 17, 2014) to a high of $12.2923 (Jul 15, 2026), with a median of $7.1525 per EA.
Are there cheaper alternatives to ADDERALL 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ADDERALL 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ADDERALL 30 MG TABLET?
ADDERALL 30 MG TABLET (NDC 57844013001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand (anda) product.
Is ADDERALL 30 MG TABLET in shortage?
Yes — NDC 57844013001 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).